{"gene":"POLR3B","run_date":"2026-04-28T19:45:44","timeline":{"discoveries":[{"year":2007,"finding":"The zebrafish polr3b splice-site mutation (slim jim) causes deletion of 41 amino acids in Polr3b that impairs its interaction with Polr3k (ortholog of yeast Rpc11), resulting in markedly reduced levels of Rpc11p in the Pol III complex; overexpression of polr3k rescued the exocrine phenotype, demonstrating functional conservation of Polr3b-Rpc11 interaction across eukaryotes.","method":"Genetic rescue (zebrafish), engineered S. pombe rpc2-delta yeast strain, Pol III complex recovery assay, cDNA overexpression rescue","journal":"PLoS biology","confidence":"High","confidence_rationale":"Tier 1–2 — multiple orthogonal methods including engineered yeast model, zebrafish genetics, and genetic rescue; findings replicated across two organisms","pmids":["18044988"],"is_preprint":false},{"year":2011,"finding":"POLR3B encodes the second largest subunit (RPC2) of RNA Polymerase III; together with RPC1 (POLR3A), RPC2 forms the active center of the polymerase and contributes to its catalytic activity in transcribing small noncoding RNAs including 5S rRNA and all tRNAs. Splice-site and nonsense mutations in POLR3B cause loss of function via exon skipping and nonsense-mediated mRNA decay respectively.","method":"RT-PCR, sequencing, nonsense-mediated mRNA decay analysis, whole-exome sequencing","journal":"American journal of human genetics","confidence":"High","confidence_rationale":"Tier 2 — two independent papers using molecular characterization of pathogenic variants, consistent with established biochemical role of the complex","pmids":["22036172","22036171"],"is_preprint":false},{"year":2019,"finding":"The leukodystrophy-causative POLR3B R103H missense mutation severely impairs assembly of the Pol III complex, as demonstrated by proteomics in human cell lines; homozygosity for this mutation causes embryonic lethality in mice at E9.5.","method":"Proteomics (mass spectrometry), mouse genetics, embryonic lethal phenotyping","journal":"Molecular brain","confidence":"High","confidence_rationale":"Tier 2 — clean proteomics in human cells combined with in vivo mouse genetics demonstrating lethality; both orthogonal approaches consistent","pmids":["31221184"],"is_preprint":false},{"year":2021,"finding":"De novo heterozygous missense variants in POLR3B cause aberrant association of individual Pol III enzyme subunits rather than affecting overall enzyme assembly or stability, representing a distinct gain-of-function/dominant-negative pathogenic mechanism separate from the loss-of-function seen in biallelic variants.","method":"Protein modeling, proteomic analysis","journal":"American journal of human genetics","confidence":"Medium","confidence_rationale":"Tier 2–3 — proteomics and structural modeling in single study; mechanistically distinct from biallelic loss-of-function but not independently replicated","pmids":["33417887"],"is_preprint":false},{"year":2022,"finding":"POLR3B R103H disrupts Pol III assembly at specific stages; the PAQosome (HSP90 co-chaperone complex) participates in Pol III biogenesis; riluzole partly corrects the R103H assembly defect. A mass spectrometry-based assay was developed to characterize Pol III assembly stages.","method":"Mass spectrometry-based assembly assay, drug treatment (riluzole), PAQosome interaction analysis","journal":"Molecular brain","confidence":"Medium","confidence_rationale":"Tier 2 — novel MS-based reconstitution assay with functional drug rescue; single lab but multiple orthogonal approaches","pmids":["36451185"],"is_preprint":false},{"year":2016,"finding":"Intestinal epithelium-specific hypomorphic Polr3b mutation in mice causes reduced proliferation, abnormal epithelial architecture, loss of Wnt signaling, and increased apoptosis in intestinal crypts; genetic lineage tracing showed that Polr3b-deficient crypts are replaced by Cre-escaper wild-type cells, establishing an essential cell-autonomous role for Polr3b in intestinal crypt maintenance.","method":"VillinCre conditional knockout, histology, genetic lineage tracing (Rosa26-YFP), enteroid culture","journal":"Cellular and molecular gastroenterology and hepatology","confidence":"High","confidence_rationale":"Tier 2 — conditional KO with defined cellular phenotype, genetic lineage tracing, and ex vivo enteroid validation; multiple orthogonal readouts in single study","pmids":["28090567"],"is_preprint":false},{"year":2023,"finding":"The POLR3BΔ10 mutation causes a Pol III complex assembly defect (shown by affinity purification-mass spectrometry) and reduced POLR3BΔ10 protein levels in both cytoplasm and nucleus. In mice, Pdgfrα-dependent expression of the Δ10 mutant causes defective oligodendrocyte precursor proliferation and differentiation, leading to failure to produce sufficient mature oligodendrocytes during postnatal myelinogenesis, resulting in severe hypomyelination.","method":"Affinity purification-mass spectrometry, western blot, Pdgfrα-Cre/ERT conditional mouse model, immunofluorescence, immunohistochemistry, lineage tracing, spectral confocal reflectance microscopy, microCT, ex vivo MRI","journal":"Brain : a journal of neurology","confidence":"High","confidence_rationale":"Tier 1–2 — proteomics establishing assembly defect, conditional mouse model with lineage tracing defining cellular mechanism, multiple orthogonal techniques in single comprehensive study","pmids":["37635302"],"is_preprint":false},{"year":2022,"finding":"A severe HLD8-associated nonsense mutation (R550X) in POLR3B causes protein mislocalization into lysosomes (rather than nucleus), decreases lysosome-related mTOR signaling, and inhibits oligodendroglial cell morphological differentiation in an oligodendroglial precursor cell model; ibuprofen partially restores differentiation and mTOR signaling.","method":"Cell line (FBD-102b oligodendroglial precursor), immunofluorescence localization, mTOR signaling assay, morphological differentiation assay, drug treatment (ibuprofen)","journal":"Neurology international","confidence":"Medium","confidence_rationale":"Tier 3 — cell-based assays with defined phenotypic readouts; single lab, mechanistic pathway placement limited to mTOR","pmids":["35225888"],"is_preprint":false},{"year":2012,"finding":"INMAP, a truncated isoform of POLR3B, localizes to interphase nucleus and mitotic apparatus; its 209–290 amino acid region is necessary for punctate nuclear distribution; overexpression of INMAP inhibits transcriptional activity of p53 and AP-1 in a dose-dependent manner.","method":"Deletion analysis, overexpression, transcriptional reporter assays (p53, AP-1)","journal":"Molecular and cellular biochemistry","confidence":"Low","confidence_rationale":"Tier 3 — single lab, overexpression system only, no endogenous validation or mechanistic follow-up","pmids":["23124897"],"is_preprint":false},{"year":2024,"finding":"A POLR3B:c.1625A>G;p.(Asn542Ser) disease variant causes mis-splicing of POLR3B mRNA, leading to decreases in multiple Pol III subunits and TFIIIB but auto-upregulation of POLR3E (termination-reinitiation subunit); La protein accumulates relative to its pre-tRNA ligands; Pol III transcription is more deficient for tRNA genes with 4T terminators than ≥5T terminators; La knockdown independently decreases Pol III ncRNA expression; patient cells show increased tRNA fragments from pre-tRNA 3'-trailers (tRF-1) and higher miRNA levels, identifying tRF-1/tRF-3 ratios as POLR3-deficiency biomarkers.","method":"Genome-editing (HEK293 cells), small-RNAseq, transcription assays, La-knockdown, patient fibroblast RNA analysis, mass spectrometry","journal":"bioRxiv","confidence":"Medium","confidence_rationale":"Tier 2 — genome-edited cells plus patient fibroblasts, multiple orthogonal transcriptomic and functional assays; preprint only","pmids":["38410490"],"is_preprint":true}],"current_model":"POLR3B encodes the second largest catalytic subunit (RPC2) of the 17-subunit RNA Polymerase III complex, forming the active center with RPC1 (POLR3A) to transcribe small noncoding RNAs (tRNAs, 5S rRNA, snRNAs); its interaction with subunit Rpc11/POLR3K is required for RNA cleavage and Pol III recycling, its proper assembly depends on the PAQosome chaperone machinery, and loss-of-function variants impair Pol III complex assembly and oligodendrocyte precursor differentiation causing hypomyelination, while dominant de novo variants cause aberrant inter-subunit associations representing a mechanistically distinct pathogenic mode."},"narrative":{"teleology":[{"year":2007,"claim":"Establishing that POLR3B physically links the Pol III catalytic core to the POLR3K (Rpc11) subunit answered how RNA cleavage-competent Pol III is assembled, showing that a specific 41-amino-acid region of RPC2 is required for Rpc11 incorporation into the complex.","evidence":"Zebrafish polr3b splice-site mutant (slim jim) combined with engineered S. pombe rpc2-Δ yeast strain; genetic rescue by polr3k overexpression across two organisms","pmids":["18044988"],"confidence":"High","gaps":["Structural basis of the RPC2–Rpc11 interaction at atomic resolution was not determined","Whether this interaction is regulated or constitutive in vivo remains unknown"]},{"year":2011,"claim":"Identification of biallelic POLR3B mutations in leukodystrophy patients established that POLR3B loss of function causes human disease, with splice-site mutations leading to exon skipping and nonsense mutations triggering NMD, linking the Pol III catalytic subunit to central nervous system myelination.","evidence":"Whole-exome sequencing of leukodystrophy families; RT-PCR and NMD analysis of patient cells","pmids":["22036172","22036171"],"confidence":"High","gaps":["Cell-type-specific vulnerability (why oligodendrocytes are disproportionately affected) was not explained","Quantitative impact on Pol III transcriptome was not measured"]},{"year":2016,"claim":"Demonstrating that Polr3b is cell-autonomously required for intestinal crypt maintenance revealed an essential proliferative role outside the nervous system, with loss causing Wnt signaling collapse and apoptosis in transit-amplifying compartments.","evidence":"VillinCre conditional knockout in mice with Rosa26-YFP lineage tracing and enteroid culture","pmids":["28090567"],"confidence":"High","gaps":["Whether the intestinal phenotype reflects global tRNA insufficiency or loss of specific Pol III transcripts is unknown","Relevance to human intestinal pathology in POLR3B patients not established"]},{"year":2019,"claim":"Showing that the leukodystrophy-causative R103H mutation severely impairs Pol III complex assembly and causes embryonic lethality in homozygous mice established that defective complex biogenesis, not just reduced catalytic activity, is a primary pathogenic mechanism.","evidence":"Affinity purification–mass spectrometry in human cell lines; R103H homozygous mouse lethality at E9.5","pmids":["31221184"],"confidence":"High","gaps":["Which specific assembly intermediate is disrupted by R103H was not resolved","No conditional or heterozygous phenotyping in neural lineages was performed"]},{"year":2021,"claim":"Discovery that de novo heterozygous POLR3B missense variants cause aberrant inter-subunit associations — rather than global assembly loss — established a mechanistically distinct dominant-negative or gain-of-function pathogenic mode separate from biallelic loss of function.","evidence":"Proteomic analysis and structural modeling of de novo variants","pmids":["33417887"],"confidence":"Medium","gaps":["Not independently replicated in a second cohort or lab","Functional consequence on Pol III transcription not directly measured","Precise nature of aberrant subunit interactions (stoichiometry, stability) unresolved"]},{"year":2022,"claim":"Resolving the R103H assembly defect to specific stages and identifying the PAQosome as a chaperone for Pol III biogenesis opened a therapeutic axis, as riluzole partially corrected the assembly defect.","evidence":"Mass spectrometry-based assembly assay, PAQosome interaction analysis, riluzole drug treatment in cell lines","pmids":["36451185"],"confidence":"Medium","gaps":["Riluzole mechanism of rescue not defined at molecular level","PAQosome contribution to Pol III biogenesis not validated in vivo","Whether other disease variants respond similarly is untested"]},{"year":2022,"claim":"Demonstrating that the R550X nonsense mutation mislocalizes truncated POLR3B protein to lysosomes and diminishes mTOR signaling in oligodendroglial precursors provided a mechanistic link between Pol III deficiency and impaired oligodendrocyte differentiation.","evidence":"FBD-102b oligodendroglial precursor cell model, immunofluorescence, mTOR signaling assay, ibuprofen rescue","pmids":["35225888"],"confidence":"Medium","gaps":["Single cell-line model without in vivo confirmation","Whether lysosomal mislocalization occurs with other truncating mutations unknown","mTOR pathway involvement not validated in patient-derived cells"]},{"year":2023,"claim":"A conditional mouse model expressing POLR3BΔ10 in oligodendrocyte precursors demonstrated that Pol III assembly defects directly impair OPC proliferation and differentiation, producing severe hypomyelination and establishing the cell-autonomous basis of POLR3-related leukodystrophy.","evidence":"Pdgfrα-Cre/ERT conditional knock-in mouse; AP-MS, lineage tracing, spectral confocal reflectance microscopy, ex vivo MRI","pmids":["37635302"],"confidence":"High","gaps":["Specific Pol III transcripts limiting OPC differentiation not identified","Whether mature oligodendrocytes are also vulnerable to POLR3B deficiency is untested"]},{"year":2024,"claim":"Characterization of a mis-splicing variant revealed that POLR3B deficiency differentially affects tRNA genes based on terminator strength, causes compensatory POLR3E upregulation, and generates tRF-1/tRF-3 ratio shifts as potential biomarkers, providing the first detailed picture of how reduced Pol III activity reshapes the small noncoding transcriptome.","evidence":"(preprint) Genome-edited HEK293 cells, small-RNAseq, patient fibroblast RNA analysis, La-knockdown, mass spectrometry","pmids":["38410490"],"confidence":"Medium","gaps":["Preprint not yet peer-reviewed","tRF biomarker utility not validated in an independent patient cohort","Whether terminator-strength-dependent deficiency is general across POLR3B variants is unknown"]},{"year":null,"claim":"The identity of the specific Pol III transcripts whose reduction most critically drives oligodendrocyte precursor failure — and whether therapeutic restoration of individual transcripts or chaperone-assisted complex assembly can rescue myelination in vivo — remains the central open question.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No single-cell Pol III transcriptome profiling during myelinogenesis","No in vivo pharmacological rescue of hypomyelination demonstrated","Structural basis of disease-variant-specific assembly defects not resolved at atomic level"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0003677","term_label":"DNA binding","supporting_discovery_ids":[1]},{"term_id":"GO:0140098","term_label":"catalytic activity, acting on RNA","supporting_discovery_ids":[0,1]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[6,8]},{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[6]}],"pathway":[{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[0,1,9]},{"term_id":"R-HSA-8953854","term_label":"Metabolism of RNA","supporting_discovery_ids":[0,1,9]}],"complexes":["RNA Polymerase III"],"partners":["POLR3A","POLR3K","POLR3E"],"other_free_text":[]},"mechanistic_narrative":"POLR3B encodes the second largest catalytic subunit (RPC2) of the 17-subunit RNA Polymerase III complex, forming the active center with RPC1 (POLR3A) to transcribe small noncoding RNAs including tRNAs and 5S rRNA [PMID:22036172]. Its interaction with the POLR3K (Rpc11) subunit is required for Pol III function, as demonstrated by cross-species rescue experiments, and proper Pol III complex assembly depends on the PAQosome chaperone machinery [PMID:18044988, PMID:36451185]. POLR3B is essential for proliferating tissues: conditional loss in mouse intestinal epithelium abolishes crypt maintenance via loss of Wnt signaling [PMID:28090567], and in oligodendrocyte precursors it impairs proliferation and differentiation, causing severe hypomyelination characteristic of POLR3-related leukodystrophy (HLD8), where biallelic loss-of-function variants disrupt complex assembly while de novo heterozygous missense variants cause aberrant inter-subunit associations representing a mechanistically distinct dominant pathogenic mode [PMID:37635302, PMID:33417887]."},"prefetch_data":{"uniprot":{"accession":"Q9NW08","full_name":"DNA-directed RNA polymerase III subunit RPC2","aliases":["C128","DNA-directed RNA polymerase III 127.6 kDa polypeptide","DNA-directed RNA polymerase III subunit B"],"length_aa":1133,"mass_kda":127.8,"function":"Catalytic core component of RNA polymerase III (Pol III), a DNA-dependent RNA polymerase which synthesizes small non-coding RNAs using the four ribonucleoside triphosphates as substrates. Synthesizes 5S rRNA, snRNAs, tRNAs and miRNAs from at least 500 distinct genomic loci (PubMed:20413673, PubMed:33558766). Pol III-mediated transcription cycle proceeds through transcription initiation, transcription elongation and transcription termination stages. During transcription initiation, Pol III is recruited to DNA promoters type I, II or III with the help of general transcription factors and other specific initiation factors. Once the polymerase has escaped from the promoter it enters the elongation phase during which RNA is actively polymerized, based on complementarity with the template DNA strand. Transcription termination involves the release of the RNA transcript and polymerase from the DNA (PubMed:20413673, PubMed:33335104, PubMed:33558764, PubMed:33558766, PubMed:33674783, PubMed:34675218). Forms Pol III active center together with the largest subunit POLR3A/RPC1. A single-stranded DNA template strand of the promoter is positioned within the central active site cleft of Pol III. Appends one nucleotide at a time to the 3' end of the nascent RNA, with POLR3A/RPC1 contributing a Mg(2+)-coordinating DxDGD motif, and POLR3B/RPC2 participating in the coordination of a second Mg(2+) ion and providing lysine residues believed to facilitate Watson-Crick base pairing between the incoming nucleotide and template base. Typically, Mg(2+) ions direct a 5' nucleoside triphosphate to form a phosphodiester bond with the 3' hydroxyl of the preceding nucleotide of the nascent RNA, with the elimination of pyrophosphate (PubMed:19609254, PubMed:20413673, PubMed:33335104, PubMed:33558764, PubMed:33674783, PubMed:34675218). Pol III plays a key role in sensing and limiting infection by intracellular bacteria and DNA viruses. Acts as a nuclear and cytosolic DNA sensor involved in innate immune response. Can sense non-self dsDNA that serves as template for transcription into dsRNA. The non-self RNA polymerase III transcripts, such as Epstein-Barr virus-encoded RNAs (EBERs) induce type I interferon and NF-kappa-B through the RIG-I pathway","subcellular_location":"Nucleus; Cytoplasm, cytosol","url":"https://www.uniprot.org/uniprotkb/Q9NW08/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":true,"resolved_as":"","url":"https://depmap.org/portal/gene/POLR3B","classification":"Common Essential","n_dependent_lines":1202,"n_total_lines":1208,"dependency_fraction":0.9950331125827815},"opencell":{"profiled":true,"resolved_as":"","ensg_id":"ENSG00000013503","cell_line_id":"CID000710","localizations":[{"compartment":"nuclear_punctae","grade":3},{"compartment":"nucleoplasm","grade":2}],"interactors":[{"gene":"POLR2E","stoichiometry":10.0},{"gene":"POLR2H","stoichiometry":10.0},{"gene":"POLR2K","stoichiometry":10.0},{"gene":"POLR3A","stoichiometry":10.0},{"gene":"TRMT1L","stoichiometry":10.0},{"gene":"POLR3E","stoichiometry":10.0},{"gene":"POLR3H","stoichiometry":10.0},{"gene":"POLR3F","stoichiometry":10.0},{"gene":"POLR3GL","stoichiometry":10.0},{"gene":"POLR3C","stoichiometry":10.0}],"url":"https://opencell.sf.czbiohub.org/target/CID000710","total_profiled":1310},"omim":[{"mim_id":"619742","title":"CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1I; CMT1I","url":"https://www.omim.org/entry/619742"},{"mim_id":"616494","title":"LEUKODYSTROPHY, HYPOMYELINATING, 11; HLD11","url":"https://www.omim.org/entry/616494"},{"mim_id":"614381","title":"LEUKODYSTROPHY, HYPOMYELINATING, 8, WITH OR WITHOUT OLIGODONTIA AND/OR HYPOGONADOTROPIC HYPOGONADISM; HLD8","url":"https://www.omim.org/entry/614381"},{"mim_id":"614366","title":"POLYMERASE III, RNA, SUBUNIT B; POLR3B","url":"https://www.omim.org/entry/614366"},{"mim_id":"614258","title":"POLYMERASE III, RNA, SUBUNIT A; POLR3A","url":"https://www.omim.org/entry/614258"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Nuclear speckles","reliability":"Approved"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/POLR3B"},"hgnc":{"alias_symbol":["RPC2","FLJ10388","C128"],"prev_symbol":[]},"alphafold":{"accession":"Q9NW08","domains":[{"cath_id":"3.90.1100.10","chopping":"40-181_361-464_490-495","consensus_level":"high","plddt":89.3485,"start":40,"end":495},{"cath_id":"3.90.1110.10","chopping":"185-355","consensus_level":"medium","plddt":86.6927,"start":185,"end":355},{"cath_id":"3.90.1070.20","chopping":"501-663","consensus_level":"high","plddt":90.5926,"start":501,"end":663},{"cath_id":"2.40.270.10","chopping":"673-688_720-768_891-1010","consensus_level":"high","plddt":94.2743,"start":673,"end":1010},{"cath_id":"2.40.50.150","chopping":"774-836_850-888","consensus_level":"high","plddt":89.9553,"start":774,"end":888},{"cath_id":"3.90.1800.10","chopping":"1048-1119","consensus_level":"medium","plddt":93.3646,"start":1048,"end":1119}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9NW08","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q9NW08-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q9NW08-F1-predicted_aligned_error_v6.png","plddt_mean":89.0},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=POLR3B","jax_strain_url":"https://www.jax.org/strain/search?query=POLR3B"},"sequence":{"accession":"Q9NW08","fasta_url":"https://rest.uniprot.org/uniprotkb/Q9NW08.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q9NW08/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9NW08"}},"corpus_meta":[{"pmid":"25339210","id":"PMC_25339210","title":"Clinical spectrum of 4H leukodystrophy caused by POLR3A and POLR3B mutations.","date":"2014","source":"Neurology","url":"https://pubmed.ncbi.nlm.nih.gov/25339210","citation_count":171,"is_preprint":false},{"pmid":"22036172","id":"PMC_22036172","title":"Recessive mutations in POLR3B, encoding the second largest subunit of Pol III, cause a rare hypomyelinating leukodystrophy.","date":"2011","source":"American journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/22036172","citation_count":141,"is_preprint":false},{"pmid":"22036171","id":"PMC_22036171","title":"Mutations in POLR3A and POLR3B encoding RNA Polymerase III subunits cause an autosomal-recessive hypomyelinating leukoencephalopathy.","date":"2011","source":"American journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/22036171","citation_count":137,"is_preprint":false},{"pmid":"23355746","id":"PMC_23355746","title":"Mutations in POLR3A and POLR3B are a major cause of hypomyelinating leukodystrophies with or without dental abnormalities and/or hypogonadotropic hypogonadism.","date":"2013","source":"Journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/23355746","citation_count":90,"is_preprint":false},{"pmid":"20126794","id":"PMC_20126794","title":"The DC gate in Channelrhodopsin-2: crucial hydrogen bonding interaction between C128 and D156.","date":"2010","source":"Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology","url":"https://pubmed.ncbi.nlm.nih.gov/20126794","citation_count":72,"is_preprint":false},{"pmid":"18044988","id":"PMC_18044988","title":"Mutation of RNA Pol III subunit rpc2/polr3b Leads to Deficiency of Subunit Rpc11 and disrupts zebrafish digestive development.","date":"2007","source":"PLoS biology","url":"https://pubmed.ncbi.nlm.nih.gov/18044988","citation_count":61,"is_preprint":false},{"pmid":"27512013","id":"PMC_27512013","title":"Phenotypic spectrum of POLR3B mutations: isolated hypogonadotropic hypogonadism without neurological or dental anomalies.","date":"2016","source":"Journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/27512013","citation_count":40,"is_preprint":false},{"pmid":"31221184","id":"PMC_31221184","title":"The leukodystrophy mutation Polr3b R103H causes homozygote mouse embryonic lethality and impairs RNA polymerase III biogenesis.","date":"2019","source":"Molecular brain","url":"https://pubmed.ncbi.nlm.nih.gov/31221184","citation_count":32,"is_preprint":false},{"pmid":"23643445","id":"PMC_23643445","title":"Different patterns of cerebellar abnormality and hypomyelination between POLR3A and POLR3B mutations.","date":"2013","source":"Brain & development","url":"https://pubmed.ncbi.nlm.nih.gov/23643445","citation_count":23,"is_preprint":false},{"pmid":"33417887","id":"PMC_33417887","title":"De novo variants in POLR3B cause ataxia, spasticity, and demyelinating neuropathy.","date":"2021","source":"American journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/33417887","citation_count":23,"is_preprint":false},{"pmid":"26045207","id":"PMC_26045207","title":"Large exonic deletions in POLR3B gene cause POLR3-related leukodystrophy.","date":"2015","source":"Orphanet journal of rare diseases","url":"https://pubmed.ncbi.nlm.nih.gov/26045207","citation_count":22,"is_preprint":false},{"pmid":"27471578","id":"PMC_27471578","title":"Complete genome of Nitrosospira briensis C-128, an ammonia-oxidizing bacterium from agricultural soil.","date":"2016","source":"Standards in genomic sciences","url":"https://pubmed.ncbi.nlm.nih.gov/27471578","citation_count":22,"is_preprint":false},{"pmid":"26011300","id":"PMC_26011300","title":"POLR3A and POLR3B Mutations in Unclassified Hypomyelination.","date":"2015","source":"Neuropediatrics","url":"https://pubmed.ncbi.nlm.nih.gov/26011300","citation_count":15,"is_preprint":false},{"pmid":"26478204","id":"PMC_26478204","title":"Recessive Mutations in POLR3B Encoding RNA Polymerase III Subunit Causing Diffuse Hypomyelination in Patients with 4H Leukodystrophy with Polymicrogyria and Cataracts.","date":"2015","source":"Clinical neuroradiology","url":"https://pubmed.ncbi.nlm.nih.gov/26478204","citation_count":14,"is_preprint":false},{"pmid":"28090567","id":"PMC_28090567","title":"The RNA polymerase III subunit Polr3b is required for the maintenance of small intestinal crypts in mice.","date":"2016","source":"Cellular and molecular gastroenterology and hepatology","url":"https://pubmed.ncbi.nlm.nih.gov/28090567","citation_count":12,"is_preprint":false},{"pmid":"32319736","id":"PMC_32319736","title":"4H leukodystrophy caused by a homozygous POLR3B mutation: Further delineation of the phenotype.","date":"2020","source":"American journal of medical genetics. Part A","url":"https://pubmed.ncbi.nlm.nih.gov/32319736","citation_count":12,"is_preprint":false},{"pmid":"35482004","id":"PMC_35482004","title":"Novel de novo POLR3B mutations responsible for demyelinating Charcot-Marie-Tooth disease in Japan.","date":"2022","source":"Annals of clinical and translational neurology","url":"https://pubmed.ncbi.nlm.nih.gov/35482004","citation_count":10,"is_preprint":false},{"pmid":"39348199","id":"PMC_39348199","title":"POLR3B is associated with a developmental and epileptic encephalopathy with myoclonic-atonic seizures and ataxia.","date":"2024","source":"Epilepsia","url":"https://pubmed.ncbi.nlm.nih.gov/39348199","citation_count":9,"is_preprint":false},{"pmid":"37635302","id":"PMC_37635302","title":"Hypomyelination, hypodontia and craniofacial abnormalities in a Polr3b mouse model of leukodystrophy.","date":"2023","source":"Brain : a journal of neurology","url":"https://pubmed.ncbi.nlm.nih.gov/37635302","citation_count":9,"is_preprint":false},{"pmid":"34289880","id":"PMC_34289880","title":"Whole-exome sequencing reveals POLR3B variants associated with progeria-related Wiedemann-Rautenstrauch syndrome.","date":"2021","source":"Italian journal of pediatrics","url":"https://pubmed.ncbi.nlm.nih.gov/34289880","citation_count":9,"is_preprint":false},{"pmid":"37197783","id":"PMC_37197783","title":"Craniofacial features of POLR3-related leukodystrophy caused by biallelic variants in POLR3A, POLR3B and POLR1C.","date":"2023","source":"Journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/37197783","citation_count":8,"is_preprint":false},{"pmid":"36451185","id":"PMC_36451185","title":"Riluzole partially restores RNA polymerase III complex assembly in cells expressing the leukodystrophy-causative variant POLR3B R103H.","date":"2022","source":"Molecular brain","url":"https://pubmed.ncbi.nlm.nih.gov/36451185","citation_count":7,"is_preprint":false},{"pmid":"23124897","id":"PMC_23124897","title":"INMAP, a novel truncated version of POLR3B, represses AP-1 and p53 transcriptional activity.","date":"2012","source":"Molecular and cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/23124897","citation_count":6,"is_preprint":false},{"pmid":"31577365","id":"PMC_31577365","title":"POLR3B-associated leukodystrophy: clinical, neuroimaging and molecular-genetic analyses in four patients: clinical heterogeneity and novel mutations in POLR3B gene.","date":"2019","source":"Neurologia i neurochirurgia polska","url":"https://pubmed.ncbi.nlm.nih.gov/31577365","citation_count":6,"is_preprint":false},{"pmid":"36650939","id":"PMC_36650939","title":"Identification of POLR3B biallelic mutations-associated hypomyelinating leukodystrophy-8 in two siblings.","date":"2023","source":"Clinical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/36650939","citation_count":4,"is_preprint":false},{"pmid":"35436926","id":"PMC_35436926","title":"Intellectual disability associated with craniofacial dysmorphism due to POLR3B mutation and defect in spliceosomal machinery.","date":"2022","source":"BMC medical genomics","url":"https://pubmed.ncbi.nlm.nih.gov/35436926","citation_count":4,"is_preprint":false},{"pmid":"36042647","id":"PMC_36042647","title":"Case report: Biallelic variants in POLR3B gene lead to 4H leukodystrophy from the study of brother and sister.","date":"2022","source":"Medicine","url":"https://pubmed.ncbi.nlm.nih.gov/36042647","citation_count":4,"is_preprint":false},{"pmid":"35434302","id":"PMC_35434302","title":"The First Korean Siblings With Adult-Onset 4H Leukodystrophy Related to Nonsynonymous POLR3B Mutations.","date":"2022","source":"Neurology. Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/35434302","citation_count":3,"is_preprint":false},{"pmid":"38465473","id":"PMC_38465473","title":"Polr3b heterozygosity in mice induces both beneficial and deleterious effects on health during ageing with no effect on lifespan.","date":"2024","source":"Aging cell","url":"https://pubmed.ncbi.nlm.nih.gov/38465473","citation_count":3,"is_preprint":false},{"pmid":"38002527","id":"PMC_38002527","title":"A New Case of Autosomal-Dominant POLR3B-Related Disorder: Widening Genotypic and Phenotypic Spectrum.","date":"2023","source":"Brain sciences","url":"https://pubmed.ncbi.nlm.nih.gov/38002527","citation_count":3,"is_preprint":false},{"pmid":"37897416","id":"PMC_37897416","title":"A novel de novo variant in POLR3B gene associated with a primary axonal involvement of the largest nerve fibers.","date":"2023","source":"Journal of the peripheral nervous system : JPNS","url":"https://pubmed.ncbi.nlm.nih.gov/37897416","citation_count":3,"is_preprint":false},{"pmid":"37554900","id":"PMC_37554900","title":"Uncertain significance mutation in the POLR3B gene in a Syrian boy with leukodystrophy: a case report.","date":"2023","source":"Annals of medicine and surgery (2012)","url":"https://pubmed.ncbi.nlm.nih.gov/37554900","citation_count":2,"is_preprint":false},{"pmid":"39178560","id":"PMC_39178560","title":"POLR3B de novo variants are a rare cause of infantile myoclonic epilepsy.","date":"2024","source":"Seizure","url":"https://pubmed.ncbi.nlm.nih.gov/39178560","citation_count":2,"is_preprint":false},{"pmid":"38410490","id":"PMC_38410490","title":"A POLR3B-variant reveals a Pol III transcriptome response dependent on La protein/SSB.","date":"2024","source":"bioRxiv : the preprint server for biology","url":"https://pubmed.ncbi.nlm.nih.gov/38410490","citation_count":1,"is_preprint":false},{"pmid":"35225888","id":"PMC_35225888","title":"Hypomyelinating Leukodystrophy 8 (HLD8)-Associated Mutation of POLR3B Leads to Defective Oligodendroglial Morphological Differentiation Whose Effect Is Reversed by Ibuprofen.","date":"2022","source":"Neurology international","url":"https://pubmed.ncbi.nlm.nih.gov/35225888","citation_count":1,"is_preprint":false},{"pmid":"41543137","id":"PMC_41543137","title":"Genomic architecture of the resistance to Phytophthora cactorum 2 (RPc2) locus in strawberry (Fragaria × ananassa).","date":"2026","source":"The plant genome","url":"https://pubmed.ncbi.nlm.nih.gov/41543137","citation_count":0,"is_preprint":false},{"pmid":"41640168","id":"PMC_41640168","title":"[Hypogonadotropic hypogonadism due to pathogenic variants in the POLR3B gene].","date":"2026","source":"Problemy endokrinologii","url":"https://pubmed.ncbi.nlm.nih.gov/41640168","citation_count":0,"is_preprint":false},{"pmid":"40978896","id":"PMC_40978896","title":"POLR3B-Related Hypomyelinating Leukodystrophy Type 8 (4H Syndrome): A Case Series of Two Siblings.","date":"2025","source":"Cureus","url":"https://pubmed.ncbi.nlm.nih.gov/40978896","citation_count":0,"is_preprint":false},{"pmid":null,"id":"bio_10.1101_2025.10.31.685743","title":"Diverse haplotypes at a complex  <i>Solanum americanum</i>  locus confer resistance to  <i>Phytophthora infestans</i>  and  <i>P. capsici</i>","date":"2025-10-31","source":"bioRxiv","url":"https://doi.org/10.1101/2025.10.31.685743","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2025.07.16.25331559","title":"Monoallelic <i>POLR3A</i> variants cause a Pol III-related disorder characterized by peripheral neuropathy","date":"2025-07-16","source":"bioRxiv","url":"https://doi.org/10.1101/2025.07.16.25331559","citation_count":0,"is_preprint":true}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":19920,"output_tokens":2646,"usd":0.049725},"stage2":{"model":"claude-opus-4-6","input_tokens":5975,"output_tokens":2584,"usd":0.141712},"total_usd":0.191437,"stage1_batch_id":"msgbatch_01SUR8NDzVrNmyszWyJeCct7","stage2_batch_id":"msgbatch_01G7Yfutko3cDWzejrwH5AMx","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2007,\n      \"finding\": \"The zebrafish polr3b splice-site mutation (slim jim) causes deletion of 41 amino acids in Polr3b that impairs its interaction with Polr3k (ortholog of yeast Rpc11), resulting in markedly reduced levels of Rpc11p in the Pol III complex; overexpression of polr3k rescued the exocrine phenotype, demonstrating functional conservation of Polr3b-Rpc11 interaction across eukaryotes.\",\n      \"method\": \"Genetic rescue (zebrafish), engineered S. pombe rpc2-delta yeast strain, Pol III complex recovery assay, cDNA overexpression rescue\",\n      \"journal\": \"PLoS biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — multiple orthogonal methods including engineered yeast model, zebrafish genetics, and genetic rescue; findings replicated across two organisms\",\n      \"pmids\": [\"18044988\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"POLR3B encodes the second largest subunit (RPC2) of RNA Polymerase III; together with RPC1 (POLR3A), RPC2 forms the active center of the polymerase and contributes to its catalytic activity in transcribing small noncoding RNAs including 5S rRNA and all tRNAs. Splice-site and nonsense mutations in POLR3B cause loss of function via exon skipping and nonsense-mediated mRNA decay respectively.\",\n      \"method\": \"RT-PCR, sequencing, nonsense-mediated mRNA decay analysis, whole-exome sequencing\",\n      \"journal\": \"American journal of human genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — two independent papers using molecular characterization of pathogenic variants, consistent with established biochemical role of the complex\",\n      \"pmids\": [\"22036172\", \"22036171\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"The leukodystrophy-causative POLR3B R103H missense mutation severely impairs assembly of the Pol III complex, as demonstrated by proteomics in human cell lines; homozygosity for this mutation causes embryonic lethality in mice at E9.5.\",\n      \"method\": \"Proteomics (mass spectrometry), mouse genetics, embryonic lethal phenotyping\",\n      \"journal\": \"Molecular brain\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean proteomics in human cells combined with in vivo mouse genetics demonstrating lethality; both orthogonal approaches consistent\",\n      \"pmids\": [\"31221184\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"De novo heterozygous missense variants in POLR3B cause aberrant association of individual Pol III enzyme subunits rather than affecting overall enzyme assembly or stability, representing a distinct gain-of-function/dominant-negative pathogenic mechanism separate from the loss-of-function seen in biallelic variants.\",\n      \"method\": \"Protein modeling, proteomic analysis\",\n      \"journal\": \"American journal of human genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 — proteomics and structural modeling in single study; mechanistically distinct from biallelic loss-of-function but not independently replicated\",\n      \"pmids\": [\"33417887\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"POLR3B R103H disrupts Pol III assembly at specific stages; the PAQosome (HSP90 co-chaperone complex) participates in Pol III biogenesis; riluzole partly corrects the R103H assembly defect. A mass spectrometry-based assay was developed to characterize Pol III assembly stages.\",\n      \"method\": \"Mass spectrometry-based assembly assay, drug treatment (riluzole), PAQosome interaction analysis\",\n      \"journal\": \"Molecular brain\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — novel MS-based reconstitution assay with functional drug rescue; single lab but multiple orthogonal approaches\",\n      \"pmids\": [\"36451185\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Intestinal epithelium-specific hypomorphic Polr3b mutation in mice causes reduced proliferation, abnormal epithelial architecture, loss of Wnt signaling, and increased apoptosis in intestinal crypts; genetic lineage tracing showed that Polr3b-deficient crypts are replaced by Cre-escaper wild-type cells, establishing an essential cell-autonomous role for Polr3b in intestinal crypt maintenance.\",\n      \"method\": \"VillinCre conditional knockout, histology, genetic lineage tracing (Rosa26-YFP), enteroid culture\",\n      \"journal\": \"Cellular and molecular gastroenterology and hepatology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — conditional KO with defined cellular phenotype, genetic lineage tracing, and ex vivo enteroid validation; multiple orthogonal readouts in single study\",\n      \"pmids\": [\"28090567\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"The POLR3BΔ10 mutation causes a Pol III complex assembly defect (shown by affinity purification-mass spectrometry) and reduced POLR3BΔ10 protein levels in both cytoplasm and nucleus. In mice, Pdgfrα-dependent expression of the Δ10 mutant causes defective oligodendrocyte precursor proliferation and differentiation, leading to failure to produce sufficient mature oligodendrocytes during postnatal myelinogenesis, resulting in severe hypomyelination.\",\n      \"method\": \"Affinity purification-mass spectrometry, western blot, Pdgfrα-Cre/ERT conditional mouse model, immunofluorescence, immunohistochemistry, lineage tracing, spectral confocal reflectance microscopy, microCT, ex vivo MRI\",\n      \"journal\": \"Brain : a journal of neurology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — proteomics establishing assembly defect, conditional mouse model with lineage tracing defining cellular mechanism, multiple orthogonal techniques in single comprehensive study\",\n      \"pmids\": [\"37635302\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"A severe HLD8-associated nonsense mutation (R550X) in POLR3B causes protein mislocalization into lysosomes (rather than nucleus), decreases lysosome-related mTOR signaling, and inhibits oligodendroglial cell morphological differentiation in an oligodendroglial precursor cell model; ibuprofen partially restores differentiation and mTOR signaling.\",\n      \"method\": \"Cell line (FBD-102b oligodendroglial precursor), immunofluorescence localization, mTOR signaling assay, morphological differentiation assay, drug treatment (ibuprofen)\",\n      \"journal\": \"Neurology international\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — cell-based assays with defined phenotypic readouts; single lab, mechanistic pathway placement limited to mTOR\",\n      \"pmids\": [\"35225888\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"INMAP, a truncated isoform of POLR3B, localizes to interphase nucleus and mitotic apparatus; its 209–290 amino acid region is necessary for punctate nuclear distribution; overexpression of INMAP inhibits transcriptional activity of p53 and AP-1 in a dose-dependent manner.\",\n      \"method\": \"Deletion analysis, overexpression, transcriptional reporter assays (p53, AP-1)\",\n      \"journal\": \"Molecular and cellular biochemistry\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 — single lab, overexpression system only, no endogenous validation or mechanistic follow-up\",\n      \"pmids\": [\"23124897\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"A POLR3B:c.1625A>G;p.(Asn542Ser) disease variant causes mis-splicing of POLR3B mRNA, leading to decreases in multiple Pol III subunits and TFIIIB but auto-upregulation of POLR3E (termination-reinitiation subunit); La protein accumulates relative to its pre-tRNA ligands; Pol III transcription is more deficient for tRNA genes with 4T terminators than ≥5T terminators; La knockdown independently decreases Pol III ncRNA expression; patient cells show increased tRNA fragments from pre-tRNA 3'-trailers (tRF-1) and higher miRNA levels, identifying tRF-1/tRF-3 ratios as POLR3-deficiency biomarkers.\",\n      \"method\": \"Genome-editing (HEK293 cells), small-RNAseq, transcription assays, La-knockdown, patient fibroblast RNA analysis, mass spectrometry\",\n      \"journal\": \"bioRxiv\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — genome-edited cells plus patient fibroblasts, multiple orthogonal transcriptomic and functional assays; preprint only\",\n      \"pmids\": [\"38410490\"],\n      \"is_preprint\": true\n    }\n  ],\n  \"current_model\": \"POLR3B encodes the second largest catalytic subunit (RPC2) of the 17-subunit RNA Polymerase III complex, forming the active center with RPC1 (POLR3A) to transcribe small noncoding RNAs (tRNAs, 5S rRNA, snRNAs); its interaction with subunit Rpc11/POLR3K is required for RNA cleavage and Pol III recycling, its proper assembly depends on the PAQosome chaperone machinery, and loss-of-function variants impair Pol III complex assembly and oligodendrocyte precursor differentiation causing hypomyelination, while dominant de novo variants cause aberrant inter-subunit associations representing a mechanistically distinct pathogenic mode.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"POLR3B encodes the second largest catalytic subunit (RPC2) of the 17-subunit RNA Polymerase III complex, forming the active center with RPC1 (POLR3A) to transcribe small noncoding RNAs including tRNAs and 5S rRNA [PMID:22036172]. Its interaction with the POLR3K (Rpc11) subunit is required for Pol III function, as demonstrated by cross-species rescue experiments, and proper Pol III complex assembly depends on the PAQosome chaperone machinery [PMID:18044988, PMID:36451185]. POLR3B is essential for proliferating tissues: conditional loss in mouse intestinal epithelium abolishes crypt maintenance via loss of Wnt signaling [PMID:28090567], and in oligodendrocyte precursors it impairs proliferation and differentiation, causing severe hypomyelination characteristic of POLR3-related leukodystrophy (HLD8), where biallelic loss-of-function variants disrupt complex assembly while de novo heterozygous missense variants cause aberrant inter-subunit associations representing a mechanistically distinct dominant pathogenic mode [PMID:37635302, PMID:33417887].\",\n  \"teleology\": [\n    {\n      \"year\": 2007,\n      \"claim\": \"Establishing that POLR3B physically links the Pol III catalytic core to the POLR3K (Rpc11) subunit answered how RNA cleavage-competent Pol III is assembled, showing that a specific 41-amino-acid region of RPC2 is required for Rpc11 incorporation into the complex.\",\n      \"evidence\": \"Zebrafish polr3b splice-site mutant (slim jim) combined with engineered S. pombe rpc2-Δ yeast strain; genetic rescue by polr3k overexpression across two organisms\",\n      \"pmids\": [\"18044988\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Structural basis of the RPC2–Rpc11 interaction at atomic resolution was not determined\",\n        \"Whether this interaction is regulated or constitutive in vivo remains unknown\"\n      ]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Identification of biallelic POLR3B mutations in leukodystrophy patients established that POLR3B loss of function causes human disease, with splice-site mutations leading to exon skipping and nonsense mutations triggering NMD, linking the Pol III catalytic subunit to central nervous system myelination.\",\n      \"evidence\": \"Whole-exome sequencing of leukodystrophy families; RT-PCR and NMD analysis of patient cells\",\n      \"pmids\": [\"22036172\", \"22036171\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Cell-type-specific vulnerability (why oligodendrocytes are disproportionately affected) was not explained\",\n        \"Quantitative impact on Pol III transcriptome was not measured\"\n      ]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Demonstrating that Polr3b is cell-autonomously required for intestinal crypt maintenance revealed an essential proliferative role outside the nervous system, with loss causing Wnt signaling collapse and apoptosis in transit-amplifying compartments.\",\n      \"evidence\": \"VillinCre conditional knockout in mice with Rosa26-YFP lineage tracing and enteroid culture\",\n      \"pmids\": [\"28090567\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Whether the intestinal phenotype reflects global tRNA insufficiency or loss of specific Pol III transcripts is unknown\",\n        \"Relevance to human intestinal pathology in POLR3B patients not established\"\n      ]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Showing that the leukodystrophy-causative R103H mutation severely impairs Pol III complex assembly and causes embryonic lethality in homozygous mice established that defective complex biogenesis, not just reduced catalytic activity, is a primary pathogenic mechanism.\",\n      \"evidence\": \"Affinity purification–mass spectrometry in human cell lines; R103H homozygous mouse lethality at E9.5\",\n      \"pmids\": [\"31221184\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Which specific assembly intermediate is disrupted by R103H was not resolved\",\n        \"No conditional or heterozygous phenotyping in neural lineages was performed\"\n      ]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Discovery that de novo heterozygous POLR3B missense variants cause aberrant inter-subunit associations — rather than global assembly loss — established a mechanistically distinct dominant-negative or gain-of-function pathogenic mode separate from biallelic loss of function.\",\n      \"evidence\": \"Proteomic analysis and structural modeling of de novo variants\",\n      \"pmids\": [\"33417887\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Not independently replicated in a second cohort or lab\",\n        \"Functional consequence on Pol III transcription not directly measured\",\n        \"Precise nature of aberrant subunit interactions (stoichiometry, stability) unresolved\"\n      ]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Resolving the R103H assembly defect to specific stages and identifying the PAQosome as a chaperone for Pol III biogenesis opened a therapeutic axis, as riluzole partially corrected the assembly defect.\",\n      \"evidence\": \"Mass spectrometry-based assembly assay, PAQosome interaction analysis, riluzole drug treatment in cell lines\",\n      \"pmids\": [\"36451185\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Riluzole mechanism of rescue not defined at molecular level\",\n        \"PAQosome contribution to Pol III biogenesis not validated in vivo\",\n        \"Whether other disease variants respond similarly is untested\"\n      ]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Demonstrating that the R550X nonsense mutation mislocalizes truncated POLR3B protein to lysosomes and diminishes mTOR signaling in oligodendroglial precursors provided a mechanistic link between Pol III deficiency and impaired oligodendrocyte differentiation.\",\n      \"evidence\": \"FBD-102b oligodendroglial precursor cell model, immunofluorescence, mTOR signaling assay, ibuprofen rescue\",\n      \"pmids\": [\"35225888\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Single cell-line model without in vivo confirmation\",\n        \"Whether lysosomal mislocalization occurs with other truncating mutations unknown\",\n        \"mTOR pathway involvement not validated in patient-derived cells\"\n      ]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"A conditional mouse model expressing POLR3BΔ10 in oligodendrocyte precursors demonstrated that Pol III assembly defects directly impair OPC proliferation and differentiation, producing severe hypomyelination and establishing the cell-autonomous basis of POLR3-related leukodystrophy.\",\n      \"evidence\": \"Pdgfrα-Cre/ERT conditional knock-in mouse; AP-MS, lineage tracing, spectral confocal reflectance microscopy, ex vivo MRI\",\n      \"pmids\": [\"37635302\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Specific Pol III transcripts limiting OPC differentiation not identified\",\n        \"Whether mature oligodendrocytes are also vulnerable to POLR3B deficiency is untested\"\n      ]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Characterization of a mis-splicing variant revealed that POLR3B deficiency differentially affects tRNA genes based on terminator strength, causes compensatory POLR3E upregulation, and generates tRF-1/tRF-3 ratio shifts as potential biomarkers, providing the first detailed picture of how reduced Pol III activity reshapes the small noncoding transcriptome.\",\n      \"evidence\": \"(preprint) Genome-edited HEK293 cells, small-RNAseq, patient fibroblast RNA analysis, La-knockdown, mass spectrometry\",\n      \"pmids\": [\"38410490\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Preprint not yet peer-reviewed\",\n        \"tRF biomarker utility not validated in an independent patient cohort\",\n        \"Whether terminator-strength-dependent deficiency is general across POLR3B variants is unknown\"\n      ]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"The identity of the specific Pol III transcripts whose reduction most critically drives oligodendrocyte precursor failure — and whether therapeutic restoration of individual transcripts or chaperone-assisted complex assembly can rescue myelination in vivo — remains the central open question.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"No single-cell Pol III transcriptome profiling during myelinogenesis\",\n        \"No in vivo pharmacological rescue of hypomyelination demonstrated\",\n        \"Structural basis of disease-variant-specific assembly defects not resolved at atomic level\"\n      ]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0003677\", \"supporting_discovery_ids\": [1]},\n      {\"term_id\": \"GO:0140098\", \"supporting_discovery_ids\": [0, 1]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [6, 8]},\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [6]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [0, 1, 9]},\n      {\"term_id\": \"R-HSA-8953854\", \"supporting_discovery_ids\": [0, 1, 9]}\n    ],\n    \"complexes\": [\n      \"RNA Polymerase III\"\n    ],\n    \"partners\": [\n      \"POLR3A\",\n      \"POLR3K\",\n      \"POLR3E\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}